Tiseo M - Search Results

1

Efficacy and safety of rechallenge treatment with gefitinib in patients with advanced non-small cell lung cancer.

Cappuzzo F, Morabito A, Normanno N, Bidoli P, Del Conte A, Giannetta L, Montanino A, Mazzoni F, Buosi R, Burgio MA, Cerea G, Chiari R, Cortinovis D, Finocchiaro G, Foltran L, Migliorino MR, Tiseo M, Ferrari S, De Marinis F. Cappuzzo F, et al. Among authors: tiseo m. Lung Cancer. 2016 Sep;99:31-7. doi: 10.1016/j.lungcan.2016.06.008. Epub 2016 Jun 14. Lung Cancer. 2016. PMID: 27565910 Clinical Trial.

2

Epidermal growth factor receptor targeted therapy by ZD 1839 (Iressa) in patients with brain metastases from non-small cell lung cancer (NSCLC).

Cappuzzo F, Ardizzoni A, Soto-Parra H, Gridelli C, Maione P, Tiseo M, Calandri C, Bartolini S, Santoro A, Crinò L. Cappuzzo F, et al. Among authors: tiseo m. Lung Cancer. 2003 Aug;41(2):227-31. doi: 10.1016/s0169-5002(03)00189-2. Lung Cancer. 2003. PMID: 12871787 Clinical Trial.

3

Epidermal growth factor receptor inhibitors: a new prospective in the treatment of lung cancer.

Tiseo M, Loprevite M, Ardizzoni A. Tiseo M, et al. Curr Med Chem Anticancer Agents. 2004 Mar;4(2):139-48. doi: 10.2174/1568011043482106. Curr Med Chem Anticancer Agents. 2004. PMID: 15032719 Review.

4

Second-line chemotherapy in the treatment of advanced non-small cell lung cancer (NSCLC).

Ardizzoni A, Tiseo M. Ardizzoni A, et al. Among authors: tiseo m. J Chemother. 2004 Nov;16 Suppl 4:104-7. doi: 10.1179/joc.2004.16.Supplement-1.104. J Chemother. 2004. PMID: 15688623 Review.

5

In vitro study of CI-994, a histone deacetylase inhibitor, in non-small cell lung cancer cell lines.

Loprevite M, Tiseo M, Grossi F, Scolaro T, Semino C, Pandolfi A, Favoni R, Ardizzoni A. Loprevite M, et al. Among authors: tiseo m. Oncol Res. 2005;15(1):39-48. doi: 10.3727/096504005775082066. Oncol Res. 2005. PMID: 15839304

6

Adjuvant chemotherapy for non-small cell lung cancer: ready for clinical practice?

Tiseo M, Franciosi V, Grossi F, Ardizzoni A. Tiseo M, et al. Eur J Cancer. 2006 Jan;42(1):8-16. doi: 10.1016/j.ejca.2005.08.031. Epub 2005 Nov 15. Eur J Cancer. 2006. PMID: 16293409 Review.

7

Multi-target inhibitors in non-small cell lung cancer (NSCLC).

Tiseo M, Franciosi V, Ardizzoni A. Tiseo M, et al. Ann Oncol. 2006 Mar;17 Suppl 2:ii55-57. doi: 10.1093/annonc/mdj924. Ann Oncol. 2006. PMID: 16608985 Free article. Review. No abstract available.

8

Novel targeted approaches in non-small cell lung cancer (NSCLC).

Ardizzoni A, Tiseo M. Ardizzoni A, et al. Among authors: tiseo m. Ann Oncol. 2006 May;17 Suppl 5:v91-3. doi: 10.1093/annonc/mdj959. Ann Oncol. 2006. PMID: 16807473 Free article. Review. No abstract available.

9

Decline in serum carcinoembryonic antigen and cytokeratin 19 fragment during chemotherapy predicts objective response and survival in patients with advanced nonsmall cell lung cancer.

Ardizzoni A, Cafferata MA, Tiseo M, Filiberti R, Marroni P, Grossi F, Paganuzzi M. Ardizzoni A, et al. Among authors: tiseo m. Cancer. 2006 Dec 15;107(12):2842-9. doi: 10.1002/cncr.22330. Cancer. 2006. PMID: 17103443 Free article.

10

Cisplatin- versus carboplatin-based chemotherapy in first-line treatment of advanced non-small-cell lung cancer: an individual patient data meta-analysis.

Ardizzoni A, Boni L, Tiseo M, Fossella FV, Schiller JH, Paesmans M, Radosavljevic D, Paccagnella A, Zatloukal P, Mazzanti P, Bisset D, Rosell R; CISCA (CISplatin versus CArboplatin) Meta-analysis Group. Ardizzoni A, et al. Among authors: tiseo m. J Natl Cancer Inst. 2007 Jun 6;99(11):847-57. doi: 10.1093/jnci/djk196. J Natl Cancer Inst. 2007. PMID: 17551145

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

381 results

Search Page

Filters